Efficacy and safety of trastuzumab deruxtecan in treating human epidermal growth factor receptor 2-low/positive advanced breast cancer:A meta-analysis of randomized controlled trials

Autor: Ma, Rui, Shi, Yixun, Yan, Ruijuan, Yin, Shiqing, Bu, Huanen, Huang, Jie
Zdroj: In Critical Reviews in Oncology / Hematology April 2024 196
Databáze: ScienceDirect